| Sherif Boutros, | |
|
9482 California City Blvd, California City, CA 93505-2803 | |
| (760) 373-5268 | |
| Not Available |
| Full Name | Sherif Boutros |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 9482 California City Blvd, California City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013320126 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 65237 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sherif Boutros, 9482 California City Blvd, California City, CA 93505-2803 Ph: (760) 373-5268 | Sherif Boutros, 9482 California City Blvd, California City, CA 93505-2803 Ph: (760) 373-5268 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2010, income from continuing operations was $167 million, or $0.97 per diluted share, compared to $182 million, or $0.97 per diluted share, for the fourth quarter of 2009.
StemCells, Inc. announced today that it has commenced patient recruitment for a Phase I clinical trial designed to test the safety and preliminary efficacy of its HuCNS-SC® purified human neural stem cells in Pelizaeus-Merzbacher Disease (PMD), a neurological disorder that primarily afflicts children. The study is being conducted at the University of California, San Francisco (UCSF) Children's Hospital, one of the leading medical centers in the United States for neonatology, pediatric neurology and neurosurgery.
Working with artificial intelligence, a University of Texas at Arlington researcher is developing a rapid-response supply chain designed to quickly deliver COVID-19 medications, once they are available, to vulnerable urban populations in Texas.
A review article published in the July/August 2005 Journal of Infusion Nursing examines the need for established treatment guidelines to support doctors and nurses in correctly dosing and administering intravenous immunoglobulin (IVIG) as replacement therapy in patients with primary immunodeficiency (PI) disorders, who do not produce adequate levels of antibodies essential in fighting infectious diseases.
In what is believed to be the first U.S. study designed to prevent anxiety disorders in the children of anxious parents, researchers at the Johns Hopkins Children's Center have found that a family-based program reduced symptoms and the risk of developing an anxiety disorder among these children.
› Verified 3 days ago
Gabrielle Go Kakian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9482 California City Blvd, California City, CA 93505 Phone: 760-373-5268 | |
Heejin Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9482 California City Blvd, California City, CA 93505 Phone: 760-373-5268 | |
Dr. Mohannad M Abu Alrub, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9482 California City Blvd, California City, CA 93505 Phone: 760-373-5268 | |
Dr. Jaden Binh Ong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9482 California City Blvd, California City, CA 93505 Phone: 760-373-5268 | |
Casey Diep, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9482 California City Blvd, California City, CA 93505 Phone: 760-373-5268 | |
Mr. Deon Johannnes Venter, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9482 California City Blvd, California City, CA 93505 Phone: 760-373-5268 |